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The author wishes to apologize for a mistake in [Figure 2](#bty515-F1){ref-type="fig"} in the above manuscript. The figure appears correctly below:

![When biomarkers have both prognostic/predictive strength (M-1) VT achieves higher TPR, otherwise (M-2) the gains in TPR are vanishing. In terms of $\text{FNR}_{\text{Prog}.}$, VT always has very high error rate on selecting *solely* prognostic biomarkers as predictive, and it performs worse than random selection. This is the average TPR/$\text{FNR}_{\text{Prog}.}$ over 200 simulated datasets for three different values of the predictive strength *θ*: 1/5 means a strongly prognostic signal, 1 means equal strength between prognostic and predictive signals, and 5 means a strongly predictive signal. The sample size is 2000, and the dimensionality *p* = 30 biomarkers. Dashed lines show the TPR/$\text{FNR}_{\text{Prog}.}$ if we were ranking the biomarkers at random. (**a**) **M-1:** Biomarkers can be both prognostic and predictive. (**b**) **M-2:** Biomarkers are solely either prognostic or predictive](bty515f1){#bty515-F1}

The paper has been corrected online.
